Evidence map›Paper›PMID 34877005›Full record

ArticleObesity science & practice2021

Attitudes about the treatment of obesity among healthcare providers involved in the care of obesity-related diseases: A survey across medical specialties in multiple European countries.

Francesco Rubino, Jennifer Logue, Mette Bøgelund, Maria Elmegaard Madsen, Ana-Paula Cancino, Maria Høy, Ulrik Haagen Panton

Open access · goldAbstract read
In one paragraph

Article in Obesity science & practice, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Francesco RubinoDiabetes and Nutritional Sciences King's College London London UK.
Jennifer LogueLancaster Medical School Lancaster University Lancaster UK.
Mette BøgelundIncentive Denmark Holte Denmark.
Maria Elmegaard MadsenIncentive Denmark Holte Denmark.ORCID https://orcid.org/0000-0001-6979-3764
Ana-Paula CancinoNovo Nordisk North West Europe Pharmaceuticals A/S Copenhagen Denmark.
Maria HøyNovo Nordisk North West Europe Pharmaceuticals A/S Copenhagen Denmark.
Ulrik Haagen PantonNovo Nordisk North West Europe Pharmaceuticals A/S Copenhagen Denmark.
Novo Nordisk (Denmark) · DKKing's College London · GBLancaster University · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and rationaleObesity is associated with the development and progression of many diseases. Understanding and management of obesity have become increasingly important; however, a knowledge gap remains between how healthcare providers (HCPs) consider weight-loss treatment and the importance of weight loss for improving obesity-related diseases.

objectiveThe objective of this study was to investigate how HCPs assess obesity, how they interpret the relationship between obesity and 12 recognized co-morbidities of obesity (excluding diabetes), and their view about the value of various weight-loss therapies.

methodsThis was a cross-sectional, non-interventional, descriptive study. Participants were medical doctors (HCPs) from eight European countries.

resultsEighty-nine percent of the 197 HCPs that completed the survey considered obesity a disease. For most of the 12 obesity-related diseases under consideration, a majority of HCPs agreed that weight loss could reverse the disease or prevent progression. Among HCPs who have recommended weight loss, lifestyle interventions were by far the most common recommendation. However, more than three out of four HCPs stated that they would be likely to prescribe anti-obesity medications if available and reimbursed.

conclusionMost HCPs in this survey consider obesity a disease that needs to be treated. However, the majority of HCPs appear to prefer recommending lifestyle changes, although it is well documented that weight loss obtained by lifestyle changes is difficult to maintain. These results underscore the need for improved education of HCPs involved in the treatment of obesity-related diseases.

Indexed as

anti‐obesity medicationcomplicationsHCPobesitysurvey

Identifiers

PMID34877005
PMCPMC8633947
OpenAlexW3160171011

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.